A citation-based method for searching scientific literature

T Yura, M Fukunaga, R Khan, G N Nassar, K F Badr, A Montero. Kidney Int 1999
Times Cited: 124







List of co-cited articles
834 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
J D Morrow, K E Hill, R F Burk, T M Nammour, K F Badr, L J Roberts. Proc Natl Acad Sci U S A 1990
35

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
K Takahashi, T M Nammour, M Fukunaga, J Ebert, J D Morrow, L J Roberts, R L Hoover, K F Badr. J Clin Invest 1992
462
29

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
J D Morrow, J A Awad, H J Boss, I A Blair, L J Roberts. Proc Natl Acad Sci U S A 1992
580
21

Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells.
M Fukunaga, N Makita, L J Roberts, J D Morrow, K Takahashi, K F Badr. Am J Physiol 1993
187
21

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
G Davì, G Ciabattoni, A Consoli, A Mezzetti, A Falco, S Santarone, E Pennese, E Vitacolonna, T Bucciarelli, F Costantini,[...]. Circulation 1999
595
16

Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release.
M Fukunaga, T Yura, K F Badr. J Cardiovasc Pharmacol 1995
78
19


F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.
A Montero, K A Munger, R Z Khan, J M Valdivielso, J D Morrow, A Guasch, F N Ziyadeh, K F Badr. Kidney Int 2000
80
17

Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels.
X Hou, F Gobeil, K Peri, G Speranza, A M Marrache, P Lachapelle, J Roberts, D R Varma, S Chemtob, E F Ellis. Stroke 2000
66
21

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.
J D Morrow, B Frei, A W Longmire, J M Gaziano, S M Lynch, Y Shyr, W E Strauss, J A Oates, L J Roberts. N Engl J Med 1995
13

A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels.
I Lahaie, P Hardy, X Hou, H Hasséssian, P Asselin, P Lachapelle, G Almazan, D R Varma, J D Morrow, L J Roberts,[...]. Am J Physiol 1998
87
14



8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.
N Delanty, M P Reilly, D Pratico, J A Lawson, J F McCarthy, A E Wood, S T Ohnishi, D J Fitzgerald, G A FitzGerald. Circulation 1997
239
12

Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.
J D Morrow, T A Minton, C R Mukundan, M D Campbell, W E Zackert, V C Daniel, K F Badr, I A Blair, L J Roberts. J Biol Chem 1994
240
11

A nomenclature system for the isoprostanes.
D F Taber, J D Morrow, L J Roberts. Prostaglandins 1997
145
11


Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
M Fukunaga, T Yura, R Grygorczyk, K F Badr. Am J Physiol 1997
72
15

Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
D Praticò, L Iuliano, A Mauriello, L Spagnoli, J A Lawson, J Rokach, J Maclouf, F Violi, G A FitzGerald. J Clin Invest 1997
289
10

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.
N K Gopaul, E E Anggård, A I Mallet, D J Betteridge, S P Wolff, J Nourooz-Zadeh. FEBS Lett 1995
329
10

Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells.
J Kähler, A Ewert, J Weckmüller, S Stobbe, C Mittmann, R Köster, M Paul, T Meinertz, T Münzel. J Cardiovasc Pharmacol 2001
116
10



Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo.
L P Audoly, B Rocca, J E Fabre, B H Koller, D Thomas, A L Loeb, T M Coffman, G A FitzGerald. Circulation 2000
158
10

Vascular biology of the isoprostanes.
J L Cracowski, P Devillier, T Durand, F Stanke-Labesque, G Bessard. J Vasc Res 2001
91
10

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
Edzard Schwedhelm, Asja Bartling, Henrike Lenzen, Dimitrios Tsikas, Renke Maas, Jens Brümmer, Frank-Mathias Gutzki, Jürgen Berger, Jürgen C Frölich, Rainer H Böger. Circulation 2004
214
10

Isoprostanes: markers and mediators of oxidative stress.
Paolo Montuschi, Peter J Barnes, L Jackson Roberts. FASEB J 2004
480
10


The isoprostane 8-iso-PGF(2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation.
N Leitinger, J Huber, C Rizza, D Mechtcheriakova, V Bochkov, Y Koshelnick, J A Berliner, B R Binder. FASEB J 2001
53
16

Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome.
J D Morrow, K P Moore, J A Awad, M D Ravenscraft, G Marini, K F Badr, R Williams, L J Roberts. J Lipid Mediat 1993
99
9

Antioxidants block angiotensin II-induced increases in blood pressure and endothelin.
M C Ortiz, M C Manriquez, J C Romero, L A Juncos. Hypertension 2001
106
9





Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
C Patrono, G A FitzGerald. Arterioscler Thromb Vasc Biol 1997
373
9

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
M B Kadiiska, B C Gladen, D D Baird, D Germolec, L B Graham, C E Parker, A Nyska, J T Wachsman, B N Ames, S Basu,[...]. Free Radic Biol Med 2005
485
9



Isoprostanes: an overview and putative roles in pulmonary pathophysiology.
L J Janssen. Am J Physiol Lung Cell Mol Physiol 2001
180
8

Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles.
L J Janssen, M Premji, S Netherton, J Coruzzi, H Lu-Chao, P G Cox. Br J Pharmacol 2001
65
12


2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
X Hou, L J Roberts, D F Taber, J D Morrow, K Kanai, F Gobeil, M H Beauchamp, S G Bernier, G Lepage, D R Varma,[...]. Am J Physiol Regul Integr Comp Physiol 2001
40
20

A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure.
K P Moore, S G Holt, R P Patel, D A Svistunenko, W Zackert, D Goodier, B J Reeder, M Clozel, R Anand, C E Cooper,[...]. J Biol Chem 1998
195
8

The isoprostanes in biology and medicine.
D Praticò, J A Lawson, J Rokach, G A FitzGerald. Trends Endocrinol Metab 2001
138
8


Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.
L J Roberts, T J Montine, W R Markesbery, A R Tapper, P Hardy, S Chemtob, W D Dettbarn, J D Morrow. J Biol Chem 1998
300
8

Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.
C Gniwotta, J D Morrow, L J Roberts, H Kühn. Arterioscler Thromb Vasc Biol 1997
153
7

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
M P Reilly, D Praticò, N Delanty, G DiMinno, E Tremoli, D Rader, S Kapoor, J Rokach, J Lawson, G A FitzGerald. Circulation 1998
227
7

Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats.
J F Reckelhoff, H Zhang, K Srivastava, L J Roberts, J D Morrow, J C Romero. Hypertension 2000
76
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.